Solid oral dosage form containing an enhancer

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S464000, C424S469000, C424S408000

Reexamination Certificate

active

08053429

ABSTRACT:
The invention relates to a solid oral dosage form comprising a pharmaceutically active ingredient in combination with an enhancer which enhances the bioavailability and/or the absorption of the active ingredient. Accordingly, a solid oral dosage form comprises a drug and an enhancer wherein the enhancer is a medium chain fatty acid ester, ether or salt or a derivative of a medium chain fatty acid, which is, preferably, solid at room temperature and which has a carbon chain length of from 6 to 20 carbon atoms. Preferably, the solid oral dosage form is controlled release dosage form such as a delayed release dosage form.

REFERENCES:
patent: 4525339 (1985-06-01), Behl et al.
patent: 4590062 (1986-05-01), Jang
patent: 4654155 (1987-03-01), Kipp et al.
patent: 4656161 (1987-04-01), Herr
patent: 4764375 (1988-08-01), Paradissis
patent: 4789547 (1988-12-01), Song et al.
patent: 4996058 (1991-02-01), Sinnreich
patent: 5110606 (1992-05-01), Geyer et al.
patent: 5169933 (1992-12-01), Anderson et al.
patent: 5190748 (1993-03-01), Bachynsky et al.
patent: 5221734 (1993-06-01), Burk et al.
patent: 5229130 (1993-07-01), Sharma et al.
patent: 5288497 (1994-02-01), Stanley et al.
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5444041 (1995-08-01), Owen et al.
patent: 5506207 (1996-04-01), Rivier et al.
patent: 5541155 (1996-07-01), Leone-Bay et al.
patent: 5631347 (1997-05-01), Baker et al.
patent: 5633226 (1997-05-01), Owen et al.
patent: 5639469 (1997-06-01), Benes et al.
patent: 5646109 (1997-07-01), Owen et al.
patent: 5650386 (1997-07-01), Leone-Bay et al.
patent: 5688761 (1997-11-01), Owen et al.
patent: 5707648 (1998-01-01), Yiv
patent: 5714477 (1998-02-01), Einarsson
patent: 5736161 (1998-04-01), Garces et al.
patent: 5821230 (1998-10-01), Jiang et al.
patent: 5840685 (1998-11-01), Fujii et al.
patent: 5854281 (1998-12-01), Uekama et al.
patent: 5863555 (1999-01-01), Heiber et al.
patent: 5912009 (1999-06-01), Venkateshwaran et al.
patent: 5952000 (1999-09-01), Venkateshwaran et al.
patent: 5977175 (1999-11-01), Lin
patent: 5998432 (1999-12-01), Walsh et al.
patent: 6001390 (1999-12-01), Yum et al.
patent: 6004984 (1999-12-01), Goulet et al.
patent: 6017559 (2000-01-01), Mulqueen et al.
patent: 6017944 (2000-01-01), Chu et al.
patent: 6025366 (2000-02-01), Walsh et al.
patent: 6068850 (2000-05-01), Stevenson et al.
patent: 6077847 (2000-06-01), Walsh et al.
patent: 6077858 (2000-06-01), Goulet et al.
patent: 6124261 (2000-09-01), Stevenson et al.
patent: 6147088 (2000-11-01), Goulet et al.
patent: 6150352 (2000-11-01), Goulet et al.
patent: 6150522 (2000-11-01), Goulet et al.
patent: 6156767 (2000-12-01), Goulet et al.
patent: 6156772 (2000-12-01), Goulet et al.
patent: 6200602 (2001-03-01), Watts et al.
patent: 6214798 (2001-04-01), Semple et al.
patent: 6235712 (2001-05-01), Stevenson et al.
patent: 6270804 (2001-08-01), Getz et al.
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 6372728 (2002-04-01), Ungell
patent: 6379960 (2002-04-01), Popoff et al.
patent: 6468559 (2002-10-01), Chen et al.
patent: 6638530 (2003-10-01), Ishibashi et al.
patent: 6747014 (2004-06-01), Teng et al.
patent: 6747125 (2004-06-01), Hoeger et al.
patent: 6875843 (2005-04-01), Jacobson
patent: 6949258 (2005-09-01), Zhang
patent: 7098305 (2006-08-01), Deghenghi et al.
patent: 7154002 (2006-12-01), Bressi et al.
patent: 7214662 (2007-05-01), Sarlikiotis et al.
patent: 7410957 (2008-08-01), Bauss et al.
patent: 7658938 (2010-02-01), Cumming et al.
patent: 7670626 (2010-03-01), Clancy et al.
patent: 7704977 (2010-04-01), Leonard
patent: 2002/0002140 (2002-01-01), Holick et al.
patent: 2003/0091623 (2003-05-01), Cumming et al.
patent: 2003/0139378 (2003-07-01), Daifotis et al.
patent: 2003/0176397 (2003-09-01), Lichtenberger
patent: 2003/0181421 (2003-09-01), Horowitz et al.
patent: 2004/0087631 (2004-05-01), Bacopoulos et al.
patent: 2004/0147484 (2004-07-01), Boyd et al.
patent: 2004/0157799 (2004-08-01), Seaman et al.
patent: 2005/0080075 (2005-04-01), Nichols et al.
patent: 2005/0157799 (2005-07-01), Raman
patent: 2005/0232981 (2005-10-01), Ben-Sasson
patent: 2006/0210639 (2006-09-01), Liversidge et al.
patent: 2007/0021357 (2007-01-01), Tobia et al.
patent: 2007/0021378 (2007-01-01), Varki et al.
patent: 2007/0060509 (2007-03-01), Kanikanti et al.
patent: 2007/0148228 (2007-06-01), Cumming et al.
patent: 2007/0196464 (2007-08-01), Cumming et al.
patent: 2007/0212395 (2007-09-01), Donello et al.
patent: 2007/0219131 (2007-09-01), Ben-Sasson
patent: 2007/0238707 (2007-10-01), Leonard
patent: 2007/0292512 (2007-12-01), Leonard et al.
patent: 2008/0171848 (2008-07-01), Christiansen et al.
patent: 2008/0275001 (2008-11-01), Cumming et al.
patent: 2009/0004281 (2009-01-01), Nghiem et al.
patent: 2009/0060861 (2009-03-01), Poulsen
patent: 2009/0274758 (2009-11-01), Pinhasi et al.
patent: 2009/0280169 (2009-11-01), Leonard
patent: 2009/0280170 (2009-11-01), Lee et al.
patent: 2010/0105627 (2010-04-01), Salama et al.
patent: 0370481 (1989-11-01), None
patent: 0376534 (1990-07-01), None
patent: 0497162 (1992-08-01), None
patent: 0517211 (1992-12-01), None
patent: 0580074 (1994-01-01), None
patent: 0747390 (1996-12-01), None
patent: 0667148 (2002-07-01), None
patent: 1246839 (2004-06-01), None
patent: 1674082 (2006-06-01), None
patent: 1339411 (2007-07-01), None
patent: 953626 (1964-03-01), None
patent: (11)63119 (1995-03-01), None
patent: 59073600 (1984-04-01), None
patent: 02180837 (1990-07-01), None
patent: 2282327 (1990-11-01), None
patent: 03275633 (1991-12-01), None
patent: 6040949 (1994-02-01), None
patent: 11035458 (1999-02-01), None
patent: 2004529953 (2004-09-01), None
patent: 2068689 (1996-11-01), None
patent: WO 84/04674 (1984-12-01), None
patent: WO 93/05903 (1993-04-01), None
patent: WO 93/21907 (1993-11-01), None
patent: WO 94/010983 (1994-05-01), None
patent: WO 95/22319 (1995-08-01), None
patent: WO 95/34294 (1995-12-01), None
patent: WO 97/05903 (1997-02-01), None
patent: WO 99/01579 (1999-01-01), None
patent: WO 99/02120 (1999-01-01), None
patent: WO 99/02485 (1999-01-01), None
patent: WO 99/45934 (1999-09-01), None
patent: WO 00/22909 (2000-04-01), None
patent: WO 00/50012 (2000-08-01), None
patent: WO 00/61111 (2000-10-01), None
patent: WO 01/89479 (2001-11-01), None
patent: WO 02/092070 (2002-11-01), None
patent: WO 03/003999 (2003-01-01), None
patent: WO 03/045419 (2003-06-01), None
patent: WO 03/047493 (2003-06-01), None
patent: WO 2005/055973 (2005-06-01), None
patent: WO 2005/063218 (2005-07-01), None
patent: WO 2006/010155 (2006-01-01), None
Fernandez at al (2007 Biochimica et Biophysica Acta 1771:633-640).
Muranishi et al (Drug Devel. Ind. Pharm. 19 929, 1993).
Morishita et al (Biol. Pharm. Bull. 16 68, 1993).
Allen, “Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems,” 8thEd., Lippincott Williams & Wilkins, 51-58 (2005).
Baker et al., “Role of Body Surface Area in Dosing of Investigatioanl Agents in Adults, 1991-2001,” J. Natl. Cancer Inst. 94:1883-1888 (2002).
Hahn, “Chemotherapy Dose Calculation and Administration in Exotic Animal Species,” Sem. Avian Exotic Pet Med. 14:193-198 (2005).
Massa et al., “3-(4-Aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a New Class of Synthetic Histone Deacetylase Inhibitors,” J. Med. Chem. 44:2069-2072 (2001).
Sawyer et al., “Body surface area as a determinant of pharmacokinetics and drug dosing,” Invest. New Drugs 19:171-177 (2001).
Sinko, “Martin's Physical Pharmacy and Pharmaceutical Sciences,” 5thEd., Lippincott Williams & Wilkins, 355-357 (2006).
U.S. Appl. No. 11/761,233, filed Jun. 11, 2007; Office Action mailed Jun. 28, 2010.
U.S. Appl. No. 12/768,008, filed Apr. 27, 2010.
U.S. Appl. No. 12/767,076, filed Apr. 26, 2010.
Moradei et al., “Histone deacetylase inhibitors: Latest developments, trends and prospects,” Curr. Med. Chem. 5(5):529-560 (2005).
U.S. Appl. No. 11/450,641, filed Jun. 9, 2006; Office Action mailed Apr. 14, 2010.
Grohganz et al., “Development and in vitro evaluation of a liposome based implant

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Solid oral dosage form containing an enhancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solid oral dosage form containing an enhancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid oral dosage form containing an enhancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4277922

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.